They are firmly convinced that synthetic organic chemistry is not only a critical enabling technology for medicine and public health, but also a field worthy of continued, energetic, and creative investigation. Research in the Carlier Group is therefore directed in both directions.
The Carlier Group is part of a research team from Virginia Tech Center for Drug Discovery that has received a $431,126 two-year grant from the National Institutes of Health to refine a Malaria drug
The Carlier Lab is housed in the Department of Chemistry at Virginia Tech and is led by
Paul Carlier, Professor of Organic and Medicinal Chemistry. Carlier is also Deputy Director of the Virginia Tech Center for Drug Discovery, an affiliated faculty member of the Vector-Borne Disease Research Group at Virginia Tech, and a member of the Executive Committee of the Virginia Drug Discovery Consortium.